GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
D83.1
Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
ICD10CM code
Medical Policies and Guidelines for Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
Related policies from health plans
ANTHEM-BLUECROSS-CT
TRANS.00029 Hematopoietic Stem Cell Transplantation for Genetic Diseases and Aplastic Anemias
ANTHEM-BLUECROSS-CT
TRANS.00029 Hematopoietic Stem Cell Transplantation for Genetic Diseases and Aplastic Anemias
ANTHEM-BLUECROSS-CT
TRANS.00029 Hematopoietic Stem Cell Transplantation for Genetic Diseases and Aplastic Anemias
Similar Codes
ICD10CM codes
D83.1
- Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
D83.8
- Other common variable immunodeficiencies
D83
- Common variable immunodeficiency
D83.0
- Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
D83.9
- Common variable immunodeficiency, unspecified
D83.2
- Common variable immunodeficiency with autoantibodies to B- or T-cells
D80
- Immunodeficiency with predominantly antibody defects
D80.9
- Immunodeficiency with predominantly antibody defects, unspecified
D80.8
- Other immunodeficiencies with predominantly antibody defects
D81.9
- Combined immunodeficiency, unspecified
HCPCS codes
J7599
- Immunosuppressive drug, not otherwise classified
G9223
- Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below
J0850
- Injection, cytomegalovirus immune globulin intravenous (human), per vial
G9416
- Patient had one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the
Q2043
- Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leuk
T1024
- Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to
J9311
- Injection, rituximab 10 mg and hyaluronidase
J9227
- Injection, isatuximab-irfc, 10 mg
D0431
- ADJUNCTIVE PRE-DIAGNOSTIC TEST THAT AIDS IN DETECTION OF MUCOSAL ABNORMALITIES INCLUDING PREMALIGNAN
Q2041
- Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, includi
CPT4 codes
88230
- Tissue culture for non-neoplastic disorders; lymphocyte
86360
- T cells; absolute CD4 and CD8 count, including ratio
86361
- T cells; absolute CD4 count
90399
- Unlisted immune globulin
86849
- Unlisted immunology procedure
86153
- Cell enumeration using immunologic selection and identification in fluid specimen (eg, circulating t
81263
- IGH@ (Immunoglobulin heavy chain locus) (eg, leukemia and lymphoma, B-cell), variable region somatic
86329
- Immunodiffusion; not elsewhere specified
82785
- Gammaglobulin (immunoglobulin); IgE
86644
- Antibody; cytomegalovirus (CMV)